Keywords: pharmion, raises, sales, guidance, vidaza, drugmaker, increased

Pharmion raises sales guidance for Vidaza

Article | 04 October 2004

Print This

l US drugmaker Pharmion has increased its sales guidance for Vidaza (azacitidine for injection suspension) for the second half of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in